Mainz Biomed NV | Investor Presentation Deck

Mainz Biomed NV | Investor Presentation Deck | 27 slides

Mainz Biomed · 2023-10

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 3 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem (Identify pain) 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Agitate (Make it worse) 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits

— 0/1 slides

100% 1/1 slides

— 0/1 slides

100% 1/1 slides 100% 1/1 slides Solution (Provide relief) 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides 100% 1/1 slides

Slide inventory

every slide · same image gating as the playbook

front_matter

Open slide detail

other

Open slide detail

summarize

Open slide detail

The slide uses hub-and-spoke diagrams to visually contrast decentralized vs centralized networks.compare_peers

Open slide detail

transition

Open slide detail

Includes a process diagram for the test workflow and product imagery.present_solution

Open slide detail

The slide outlines the technical workflow from sample collection to patient report generation.present_solution

Open slide detail

The slide presents clinical validation data for the ColoAlert diagnostic test.analyze_data

Open slide detail

The slide uses a 3-column layout to categorize achievements by strategic pillar.show_traction

Open slide detail

The slide uses a minimalist design with a halftone dot pattern and the company logo.transition

Open slide detail

Uses a visual timeline/process flow to explain the biological progression of CRC.frame_problem

Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction

AA = Advanced Adenoma; CRC = Colorectal Cancer. Data source cited at bottom.analyze_data

Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction

The slide uses a horizontal timeline to contrast current (2023-2024) and future (2024-2025) clinical trial phases.show_traction

Open slide detail

The slide features a thumbnail of a scientific poster presentation.show_traction

Open slide detail

The slide outlines a multi-step diagnostic process involving FIT analysis, automated extraction, qPCR, and AI/ML analysis.present_solution

Open slide detailBeat · Solution (Provide relief)Loop · Jobs To Be Done

Data presented in a summary table and two pie charts showing disease staging distribution.analyze_data

Open slide detail

Includes a highlighted box emphasizing the performance of the DNA+mRNA+FIT test for CRC and AA.analyze_data

Open slide detail

The slide uses two scatter plots to compare sensitivity vs specificity for CRC and AA, with Mainz Biomed highlighted as a top performer.compare_peers

Open slide detail

transition

Open slide detail

Includes a legend for commercial launch stars and mentions future feasibility studies for other tests.plan_implementation

Open slide detail

Slide 21 of a pitch deck.plan_implementation

Open slide detail

The slide uses a grid layout to display 9 team members with headshots, names, titles, and company logos.other

Open slide detail

The slide uses a grid layout to present 10 advisors with headshots, titles, and company logos.other

Open slide detail

The timeline uses a DNA double-helix motif to represent the company's focus on molecular diagnostics.plan_implementation